Louis Kayitalire - Jan 9, 2022 Form 4 Insider Report for F-star Therapeutics, Inc. (FSTX)

Role
Chief Medical Officer
Signature
/s/ Darlene Deptula-Hicks, Attorney-in-fact
Stock symbol
FSTX
Transactions as of
Jan 9, 2022
Transactions value $
$0
Form type
4
Date filed
1/11/2022, 04:32 PM
Previous filing
Nov 4, 2021
Next filing
Apr 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FSTX Stock Option (right to buy) Award $0 +53.6K $0.00 53.6K Jan 9, 2022 Common Stock 53.6K $4.77 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were granted under the Issuer's 2019 Equity Incentive Plan.
F2 Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, January 9, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth annual anniversary of the Vesting Commencement Date.